EchoIQ Limited

EchoIQ Limited develops AI-driven clinical decision support software for echocardiography, specifically designed to optimize structural heart damage assessment. The company's flagship platform, EchoSolv AS, leverages measurement-based AI (not image analysis) to deliver rapid, consistent insights from routine echocardiographic measurements. The platform has been developed using one of the world's largest echocardiographic datasets (200+ million measurements) and is FDA-cleared for clinical use. EchoSolv AS is designed to complement clinician review and help identify patients at risk for structural heart conditions such as aortic stenosis, delivering results in seconds at the point of clinical decision. The solution integrates into existing cardiology workflows with minimal disruption, enhancing consistency, efficiency, and throughput in echo laboratories. The company markets to cardiology departments, echo labs, and healthcare systems seeking to standardize measurements and improve diagnostic precision while maintaining clinician control and judgment.